Search

Your search keyword '"MYCOBACTERIUM bovis"' showing total 28,732 results

Search Constraints

Start Over You searched for: Descriptor "MYCOBACTERIUM bovis" Remove constraint Descriptor: "MYCOBACTERIUM bovis"
28,732 results on '"MYCOBACTERIUM bovis"'

Search Results

1. BCG as an Innovative Option for HCC Treatment: Repurposing and Mechanistic Insights.

2. Separation of mycolic acid isomers by cyclic ion mobility‐mass spectrometry.

3. A histopathological study in road-killed European badgers (Meles meles) from the English midlands with isolation of novel non-tuberculous atypical mycobacteria.

4. Molecular identification of Mycobacterium Bovis in a Franciscana (Pontoporia Blainvillei) in Patagonia, Argentina.

5. Overexpression of outer membrane protein A (OmpA) increases aminoglycoside sensitivity in mycobacteria.

6. Genetic diversities and drug resistance in Mycobacterium bovis isolates from zoonotic tuberculosis using whole genome sequencing.

7. Preliminary study of molecular identification of Mycobacterium bovis from cow's milk in Lorestan (Iran).

8. Identification and Assessment of Secondary Metabolites from Three Fungal Endophytes of Solanum mauritianum Against Public Health Pathogens.

9. Detection of Mycobacterium bovis in Free‐Ranging Sapajus nigritus, Argentina.

10. Characterization of Mycobacterium orygis, Mycobacterium bovis, and Mycobacterium caprae Infections in Humans in Western Canada.

11. Differential transcriptomic host responses in the early phase of viral and bacterial infections in human lung tissue explants ex vivo.

12. Nanoparticles target M2 macrophages to silence kallikrein-related peptidase 12 for the treatment of tuberculosis and drug-resistant tuberculosis.

13. Genomic comparison between Mycobacterium bovis and Mycobacterium microti and in silico analysis of peptide-based biomarkers for serodiagnosis.

14. Advancing meat safety diverse approaches for bovine tuberculosis detection and control in abattoirs.

15. Bovine tuberculosis in the state of Rio Grande do Norte based on secondary data.

16. 100 años después de la BCG, vacunas vivas atenuadas frente a la tuberculosis.

17. Farmer‐led badger vaccination in Cornwall: Epidemiological patterns and social perspectives.

18. Overexpression of outer membrane protein A (OmpA) increases aminoglycoside sensitivity in mycobacteria

19. Genetic diversities and drug resistance in Mycobacterium bovis isolates from zoonotic tuberculosis using whole genome sequencing

20. Preliminary study of molecular identification of Mycobacterium bovis from cow’s milk in Lorestan (Iran)

21. Farmer‐led badger vaccination in Cornwall: Epidemiological patterns and social perspectives

22. Insights into mycobacteriome composition in Mycobacterium bovis-infected African buffalo (Syncerus caffer) tissue samples

23. Phylogenetically Informative Mutations in Drug Resistance Genes of Human‐Infecting Mycobacterium bovis.

24. Reduction of hyperglycemia in STZ-induced diabetic mice by prophylactic treatment with heat-killed Mycobacterium aurum: possible effects on glucose utilization, mitochondrial uncoupling, and oxidative stress in liver and skeletal muscle.

25. Host factor RBMX2 promotes epithelial cell apoptosis by downregulating APAF-1's Retention Intron after Mycobacterium bovis infection.

26. Challenge Dose Titration in a Mycobacterium bovis Infection Model in Goats.

27. Scrofuloderma of the chest with mediastinal TB.

28. Marine sponge microbe provides insights into evolution and virulence of the tubercle bacillus.

29. A noninvasive BCG skin challenge model for assessing tuberculosis vaccine efficacy.

30. Insights into the Interplay between the Urinary Microbiome and Bladder Cancer: A Comprehensive Review.

31. Heparin-Binding Hemagglutinin of Mycobacterium tuberculosis Inhibits Autophagy via Toll-like Receptor 4 and Drives M2 Polarization in Macrophages.

32. Inside Mycobacterium bovis SB0120 spoligotype circulating in Italy: analysis of the most frequent genotypes by whole genome sequencing.

33. Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial.

34. The first insight into Mycobacterium tuberculosis complex isolates in the lower northern region in Thailand.

35. Pathogen Detection in Early Phases of Experimental Bovine Tuberculosis.

36. Characterization of a Novel Oxidative Stress Responsive Transcription Regulator in Mycobacterium bovis.

37. Facile metabolic reprogramming distinguishes mycobacterial adaptation to hypoxia and starvation: ketosis drives starvation-induced persistence in M. bovis BCG.

38. In-silico analysis of cattle blood transcriptome to identify lncRNAs and their role during bovine tuberculosis.

39. MOLECULAR EPIDEMIOLOGY OF MYCOBACTERIUM TUBERCULOSIS COMPLEX IN THE CENTER OF TUNISIA (2008-2010 AND 2014-2017).

40. A review of bovine tuberculosis transmission risk in European wildlife communities.

41. Mycobacterium bovis Infection of a Deep Brain Stimulation System Following Intravesical Bacillus Calmette-Guérin (BCG) Instillation.

42. Rapid Discovery of Antimicrobial and Antimalarial Agents from Natural Product Fragments.

43. A modified mycobacterial growth inhibition assay for the functional assessment of vaccine-mediated immunity.

44. Risk-Based Targeting of Animals for Ancillary Testing during a Bovine Tuberculosis Breakdown Is Associated with a Reduced Time to Test Failure: Indirect Evidence of Mycobacterium bovis Exposure?

45. First Insight into the Whole Genome Sequencing Whole Variations in Mycobacterium bovis from Cattle in Morocco.

46. Live Biotherapeutic Products as Cancer Treatments.

47. A scoping review on bovine tuberculosis highlights the need for novel data streams and analytical approaches to curb zoonotic diseases

48. Comparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette–Guérin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective multicenter study

49. Theories behind Bacillus Calmette-Guérin failure in high-risk non-muscle-invasive bladder cancer and update on current management

50. Development and evaluation of a triplex droplet digital PCR method for differentiation of M. tuberculosis, M. bovis and BCG.

Catalog

Books, media, physical & digital resources